Eve Health (ASX:EVE)
ASX announcement history & article coverage
Transparent by design.
Announcments by Eve Health (ASX:EVE) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Release of Securities from Escrow
Appendix 4G and Corporate Governance Statement
Annual Report to shareholders
EVE Health Group launches key pharmaceutical products, expands pipeline, raises capital, and appoints new CEO
Appendix 4E
Quarterly Activities/Appendix 4C Cash Flow Report - Amended
EVE advances Libbo pilot study, achieves apixaban solubility milestone, appoints new CEO
Quarterly Activities/Appendix 4C Cash Flow Report
EVE Health advances Libbo pilot study, achieves apixaban solubility milestone, appoints new CEO
Change of Director's Interest Notice x 3
Notification of cessation of securities - EVE
Notification of cessation of securities - EVE
Eve Initiates Pilot Clinical Study for Libbo ED Film
EVE Health launches pilot clinical study for Libbo ED oral soluble film